Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model

Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection

(2014) Radwa E. Ewaisha et al.   EXPERIMENTAL PARASITOLOGY

A multivalent chimeric vaccine composed ofSchistosoma mansoniSmTSP-2 and Sm29 was able to induce protection against infection in mice

(2014) C. S. Pinheiro et al.   PARASITE IMMUNOLOGY

Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins

(2014) Agnieszka Stryjewska et al.   Pharmacological Reports

Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis

(2013) Rosa M. Chura-Chambi et al.   JOURNAL OF BIOTECHNOLOGY

Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type

(2013) M. Firoz Mian et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Time to set the agenda for schistosomiasis elimination

(2012) David Rollinson et al.   ACTA TROPICA

Current applications of oogram methodology in experimental schistosomiasis; fecundity of female Schistosoma mansoni and egg release in the intestine of AKR/J mice following immunomodulatory treatment with pentoxifylline

(2012) V.L.T. Mati et al.   JOURNAL OF HELMINTHOLOGY

Effects of adjuvants on IgG subclasses elicited by virus-like Particles

(2012) Maria Luisa Visciano et al.   Journal of Translational Medicine

Adjuvant Selection for Vaccination against Murine Schistosomiasis

(2012) R. El Ridi et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Ultrastructural changes of adult Schistosoma mansoni worms recovered from C57BL/6 mice passively immunized with normal and vaccinated rabbit sera in vivo

(2011) Sherif H. Abdeen et al.   PARASITOLOGY RESEARCH

Miltefosine, a promising novel agent for schistosomiasis mansoni

(2010) Maha M. Eissa et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Developing vaccines to combat hookworm infection and intestinal schistosomiasis

(2010) Peter J. Hotez et al.   NATURE REVIEWS MICROBIOLOGY

Toward the Elimination of Schistosomiasis

(2009) Charles H. King   NEW ENGLAND JOURNAL OF MEDICINE

The biotechnology-value chain: Development of Sm14 as a schistosomiasis vaccine

(2008) Miriam Tendler et al.   ACTA TROPICA

Current Status of Vaccines for Schistosomiasis

(2008) D. P. McManus et al.   CLINICAL MICROBIOLOGY REVIEWS

Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000

(2008) Mohammed Bahey-El-Din et al.   Microbial Cell Factories

Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection

(2008) Luis G.C. Pacheco et al.   PARASITOLOGY INTERNATIONAL

Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model

(2008) Mohammed Bahey-El-Din et al.   VACCINE

Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection

(2008) Fernanda C. Cardoso et al.   PLoS Neglected Tropical Diseases